Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Fidelity National Information Services $2.5 billion cash tender offers
The company purchased certain debt securities
MP Materials $747.5 million convertible notes offering
The 3% convertible notes are due 2030
Surf Air Mobility up to $35.2 million sale of convertible security
We are advising Surf Air Mobility on the sale of its convertible security
Hamilton Lane $210 million follow-on offering
The shares are listed on the Nasdaq Stock Market
iRhythm Technologies $661.25 million convertible senior notes offering
The 1.5% convertible senior notes are due 2029
Sabre private exchange
We advised Sabre on its exchange of senior secured notes
Roche Holdings $3.875 billion notes offering
We advised Roche on the Rule 144A / Regulation S offering comprising four tranches of notes
Tandem Diabetes Care $316.25 million convertible senior notes offering
The 1.5% convertible senior notes are due 2029
LivaNova $345 million convertible notes offering and capped call transactions
The 2.5% convertible senior notes are due 2029
GFL Environmental $723.45 million secondary offering
The subordinate voting shares are dual-listed on the NYSE and the Toronto Stock Exchange